missing translation for 'onlineSavingsMsg'
Learn More

CD66e (CEA), clone: CB30, eBioscience™

Mouse Monoclonal Antibody

Brand:  Affymetrix eBioscience 14-0669-80

Additional Details : Weight : 0.01000kg

 View more versions of this product

Product Code. 15287047

  • 90.00 EUR / 25µg


Estimated Shipment date
from Supplier 28-05-2019
Add to basket

Description

Description

CEA (Carcino Embryonic Antigen, CD66e) is synthesized during development in the fetal gut, and re-expressed in increased amounts in intestinal carcinomas and several other tumors. CEA is a member of carcinoembryonic antigens, immunoglobulin supergene family and consists of a single N domain (structural homology to the immunoglobulin variable) and six immunoglobulin constant-like A (A1, A2, A3) and B domains (B1, B2, B3). Antibodies to CEA are useful in identifying the origin of various metastatic adenocarcinomas and in distinguishing pulmonary adenocarcinomas (60 to 70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). CEA is a member of a large family of glycoproteins, a useful tumor marker for adenocarcinoma, and found in adenocarcinomas of endodermally derived digestive system epithelium and fetal colon. Two subgroups of the CEA family, the CEA cell adhesion molecules and the pregcy-specific glycoproteins, are located within a 1.2 Mb cluster on the long arm of chromosome 19. Eleven pseudogenes of the CEA cell adhesion molecule subgroup are also found in the cluster. CEA was originally described in bile ducts of liver as biliary glycoprotein. Subsequently, CEA was found to be a cell-cell adhesion molecule detected on leukocytes, epithelia, and endothelia. The encoded protein mediates cell adhesion via homophilic as well as heterophilic binding to other proteins of the subgroup. Multiple cellular activities have been attributed to the encoded protein, including roles in the differentiation and arrangement of tissue three-dimensional structure, angiogenesis, apoptosis, tumor suppression, metastasis, and the modulation of innate and adaptive immune responses. Multiple transcript variants encoding different isoforms have been reported, but the full-length nature of all variants has not been defined.
Specifications

Specifications

CD66e (CEA)
Monoclonal
0.5 mg/mL
PBS with 0.09% sodium azide; pH 7.2
P06731
meconium antigen 100, Carcinoembryonic Antigen, CD66e
Mouse
Affinity chromatography
RUO
Antibody
Monoclonal
Human
Flow Cytometry, Immunohistochemistry (Paraffin), Western Blot
CB30
Unconjugated
CEACAM5
Liquid
CEACAM5
IgG1, kappa
25 μg
4° C
Primary
1048
Videos

For Research Use Only.